[Anticoagulants preventing pseudo-thrombocytopenia].
It is well known that some anticoagulants, especially EDTA (ethylene diamine tetraacetic acid), sometimes lead to pseudo-thrombocytopenia due to the aggregation of thrombocytes. We evaluated appropriate anticoagulants that prevent pseudo-thrombocytopenia without affecting other hematological data. In this study, 10 mg EDTA-2K and 1 mg citric acid were added to 1 ml of blood as anticoagulants. Using these anticoagulants (EC method), an aggregation of thrombocytes was clearly inhibited and the platelet counts remained stable in 10 cases with pseudo-thrombocytopenia. This method did not affect the other blood cell counts, the stainability and the morphology of the cells. Since the addition of citric acid to EDTA could prevent the cell volume change induced by the high concentration of EDTA, the micro-hematocrit values were remained unchanged. Hematological data in 20 cases which did not show any pseudo-thrombocytopenia, correlated significantly between the EDTA method and the EC method, and did not change significantly 24 hours after blood sampling. It is concluded that EDTA and citric acid may be a useful combination of anticoagulants for the prevention of pseudo-thrombocytopenia.
Nagata
T
T
Department of Clinical Laboratory and Medicine, Kyoto Prefectural University of Medicine.
Tanaka
K
K
Suzuki
K
K
Minoura
T
T
Fujita
N
N
Nakanishi
S
S
Takahashi
H
H
Yoshimura
M
M
D000925:Anticoagulants / Q000494:pharmacology*; D002951:Citrates / Q000494:pharmacology*; D019343:Citric Acid; D003864:Depression, Chemical; D004492:Edetic Acid / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013921:Thrombocytopenia / Q000097:blood*
D000925:Anticoagulants; D002951:Citrates; D010975:Platelet Aggregation Inhibitors; D019343:Citric Acid; D004492:Edetic Acid